| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1004862587 |
| P356 | DOI | 10.2165/00003088-200645090-00001 |
| P698 | PubMed publication ID | 16928150 |
| P2093 | author name string | Tong J Gan | |
| P2860 | cites work | Pharmacokinetics of midazolam in patients recovering from cardiac surgery. | Q51758707 |
| Tissue distribution of ketamine: two case reports. | Q51767921 | ||
| Propofol: clinical strategies for preventing the pain of injection. | Q51771643 | ||
| Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability? | Q51774518 | ||
| Dexmedetomidine | Q73578516 | ||
| Human physiologically based pharmacokinetic model for propofol | Q24798495 | ||
| Residual psychomotor effects following reversal of midazolam sedation with flumazenil | Q28341130 | ||
| Reversal of central benzodiazepine effects by flumazenil after conscious sedation produced by intravenous diazepam. The Flumazenil in Intravenous Conscious Sedation with Diazepam Multicenter Study Group I | Q28342793 | ||
| A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate | Q28369554 | ||
| Procedural sedation and analgesia: a review and new concepts | Q30233074 | ||
| Speed of recovery and side-effect profile of sevoflurane sedation compared with midazolam | Q31794314 | ||
| Patient-controlled analgesia and sedation in gastrointestinal endoscopy | Q33202536 | ||
| Propofol anesthesia for outpatient oral and maxillofacial surgery | Q33647094 | ||
| Pharmacokinetic and pharmacodynamic consequences of metabolism-based drug interactions with alprazolam, midazolam, and triazolam | Q33783141 | ||
| Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition | Q33834603 | ||
| Sevoflurane in paediatric anaesthesia: a review | Q33999088 | ||
| Induction speed is not a determinant of propofol pharmacodynamics | Q34074751 | ||
| RETRACTED: Comparative pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 and propofol emulsion | Q34343387 | ||
| Regional anaesthesia in the elderly: a clinical guide | Q34369550 | ||
| Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia | Q34389033 | ||
| Intravenous midazolam for upper gastrointestinal endoscopy: a study of 800 consecutive cases relating dose to age and sex of patient | Q34416278 | ||
| RETRACTED: AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 1): pharmacokinetics | Q34455237 | ||
| RETRACTED: AQUAVAN injection, a water-soluble prodrug of propofol, as a bolus injection: a phase I dose-escalation comparison with DIPRIVAN (part 2): pharmacodynamics and safety | Q34455242 | ||
| Effects of parecoxib, a parenteral COX-2-specific inhibitor, on the pharmacokinetics and pharmacodynamics of propofol | Q34468179 | ||
| Propofol. An update of its use in anaesthesia and conscious sedation | Q34731400 | ||
| Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation | Q34731567 | ||
| Comparison of propofol/fentanyl versus ketamine/midazolam for brief orthopedic procedural sedation in a pediatric emergency department | Q35167633 | ||
| Clinically Important Drug Interactions with Intravenous Anaesthetics in Older Patients | Q35560452 | ||
| Target-controlled drug delivery: progress toward an intravenous "vaporizer" and automated anesthetic administration | Q35567037 | ||
| Review article: registered nurse-administered propofol sedation for endoscopy | Q35629105 | ||
| Pharmacology and pharmacokinetics of sedatives and analgesics | Q35761942 | ||
| Update and review of moderate and deep sedation | Q35761950 | ||
| Analgesia and sedation in critically ill patients. | Q35866298 | ||
| Pharmacokinetic implications for the clinical use of propofol | Q38722656 | ||
| The pharmacology of propofol | Q38772935 | ||
| Paediatric cardiac catheterization: innovations | Q40549433 | ||
| Pharmacokinetics and pharmacodynamics of propofol/alfentanil infusions for sedation in ICU patients | Q40963700 | ||
| Nitrous oxide sedation/analgesia in emergency medicine | Q41391369 | ||
| Pharmacokinetics and pharmacodynamics of midazolam given via continuous intravenous infusion in intensive care units | Q41529360 | ||
| Pharmacokinetic and pharmacodynamic interactions between opioids and propofol | Q41582080 | ||
| Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcoholic cirrhosis | Q41858171 | ||
| Practice guidelines for sedation and analgesia by non-anesthesiologists | Q42041527 | ||
| Prolonged sedation due to accumulation of conjugated metabolites of midazolam | Q42276898 | ||
| Paradoxical reactions in children associated with midazolam use during endoscopy | Q42545834 | ||
| Recurrent respiratory depression after total intravenous anaesthesia with propofol and alfentanil | Q43070974 | ||
| Bispectral index monitoring during sedation with sevoflurane, midazolam, and propofol | Q43783518 | ||
| Clinical interpretation of pharmacokinetic and pharmacodynamic propofol-opioid interactions | Q43859594 | ||
| Pharmacokinetics and non-analgesic effects of S- and R-ketamines in healthy volunteers with normal and reduced metabolic capacity | Q43949954 | ||
| Propofol infusion rate does not affect local pain on injection | Q43958808 | ||
| Protein binding of ketamine and its active metabolites to human serum | Q43961679 | ||
| Propofol versus midazolam/meperidine for outpatient colonoscopy: administration by nurses supervised by endoscopists | Q44002782 | ||
| Patient-controlled sedation versus intravenous sedation for colonoscopy in elderly patients: a prospective randomized controlled trial | Q44192163 | ||
| Evolution of a protocol for ketamine-induced sedation as an alternative to general anesthesia for interventional radiologic procedures in pediatric patients | Q44200394 | ||
| Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%. | Q44259184 | ||
| A randomised crossover comparison of patient-controlled sedation and patient-maintained sedation using propofol | Q44369429 | ||
| Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rats | Q44371105 | ||
| Pharmacokinetics and Clinical Pharmacodynamics of the New Propofol Prodrug GPI 15715 in Volunteers: Retracted | Q44527495 | ||
| Safety of propofol for conscious sedation during endoscopic procedures in high-risk patients-a prospective, controlled study | Q44542159 | ||
| Patient-controlled sedation for colonoscopy: a randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine | Q44556447 | ||
| Analgesic effects and pharmacokinetics of a low dose of ketamine preoperatively administered epidurally or intravenously | Q44579495 | ||
| Randomized, controlled, cross-over clinical trial comparing intravenous midazolam sedation with nitrous oxide sedation in children undergoing dental extractions | Q44666227 | ||
| Nurse-administered propofol versus midazolam and meperidine for upper endoscopy in cirrhotic patients | Q44668889 | ||
| Propofol versus midazolam/fentanyl for outpatient colonoscopy: administration by nurses supervised by endoscopists | Q44797491 | ||
| Patient-controlled versus nurse-administered sedation with propofol during colonoscopy. A prospective randomized trial | Q44823739 | ||
| Safety and effectiveness of ketamine as a sedative agent for pediatric GI endoscopy | Q44870029 | ||
| Effects of low-dose midazolam with propofol in patient-controlled sedation (PCS) for apicectomy | Q44879288 | ||
| Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions. | Q44897899 | ||
| Moderate level sedation during endoscopy: a prospective study using low-dose propofol, meperidine/fentanyl, and midazolam | Q44918405 | ||
| Propofol may be safely administered by trained nonanesthesiologists. Pro: Propofol demystified: it is time to change the sedation paradigm | Q44963238 | ||
| Propofol may be safely administered by trained nonanesthesiologists. Con: Propofol: far from harmless | Q44963241 | ||
| Remifentanil used to supplement propofol does not improve quality of sedation during spontaneous respiration | Q44984499 | ||
| Paradoxical reaction following intravenous midazolam premedication in pediatric patients - a randomized placebo controlled trial of ketamine for rapid tranquilization. | Q45120700 | ||
| Changing patterns of sedation and monitoring practice during endoscopy: results of a nationwide survey in Switzerland | Q45251898 | ||
| Sedation with GPI 15715, a water-soluble prodrug of propofol, using target-controlled infusion in volunteers. | Q45280384 | ||
| Population pharmacokinetics of midazolam administered by target controlled infusion for sedation following coronary artery bypass grafting | Q46120354 | ||
| Use of midazolam and ketamine as sedation for children undergoing minor operative procedures. | Q46450732 | ||
| Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy | Q46624801 | ||
| Decreased cerebral response to inhibitory neurotransmission in alcoholics | Q48326611 | ||
| Alterations of benzodiazepine receptors in type II alcoholic subjects measured with SPECT and [123I]iomazenil | Q48352448 | ||
| Midazolam and flumazenil pharmacokinetics and pharmacodynamics following simultaneous administration to human volunteers | Q48845917 | ||
| True patient-controlled sedation | Q49125550 | ||
| Sedation with propofol plus midazolam versus propofol alone for interventional endoscopic procedures: a prospective, randomized study. | Q51382255 | ||
| Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy. | Q51392002 | ||
| Conscious sedation and cardiorespiratory safety during colonoscopy. | Q51392917 | ||
| The use of a ketamine-propofol combination during monitored anesthesia care. | Q51410121 | ||
| The effect of age on the pharmacokinetics and pharmacodynamics of midazolam. | Q51452482 | ||
| A comparison of midazolam and diazepam for conscious sedation during colonoscopy in a prospective double-blind study. | Q51457961 | ||
| Efficacy and safety of intravenous propofol sedation during routine ERCP: a prospective, controlled study. | Q51457969 | ||
| Clinical pharmacokinetics of sevoflurane. | Q51475078 | ||
| Pharmacokinetic-pharmacodynamic modeling of the coexistence of stimulatory and sedative components for midazolam. | Q51512697 | ||
| Pharmacokinetic concepts for TCI anaesthesia. | Q51514342 | ||
| Patient-maintained propofol sedation. Assessment of a target-controlled infusion system. | Q51541639 | ||
| First-pass metabolism of midazolam by the human intestine. | Q51568384 | ||
| Pharmacokinetics of ketamine enantiomers. | Q51593797 | ||
| Conscious sedation for gastroscopy: patient tolerance and cardiorespiratory parameters. | Q51608878 | ||
| Long-term sedation with propofol and green discolouration of the liver. | Q51621322 | ||
| Postoperative analgesia and sedation following pediatric cardiac surgery using a constant infusion of ketamine. | Q51667383 | ||
| Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. | Q51667750 | ||
| Pharmacokinetic and pharmacodynamic study of midazolam in children during esophagogastroduodenoscopy. | Q51706806 | ||
| Pharmacokinetics of midazolam following intravenous and oral administration in patients with chronic liver disease and in healthy subjects. | Q51756030 | ||
| P433 | issue | 9 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| pharmacodynamics | Q725307 | ||
| P304 | page(s) | 855-869 | |
| P577 | publication date | 2006-01-01 | |
| P1433 | published in | Clinical Pharmacokinetics | Q5133788 |
| P1476 | title | Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation | |
| P478 | volume | 45 |
| Q37686751 | A Prospective Randomized Trial Comparing Dexmedetomidine and Midazolam for Conscious Sedation During Oocyte Retrieval in An In Vitro Fertilization Program |
| Q93044758 | A collaborative educational intervention on procedural sedation and analgesia across the Pacific |
| Q43058231 | A comparative study on monitored anesthesia care |
| Q42063678 | A prospective randomized double-blind study comparing dexmedetomidine vs. combination of midazolam-fentanyl for tympanoplasty surgery under monitored anesthesia care |
| Q33664646 | Breakdown in cortical effective connectivity during midazolam-induced loss of consciousness |
| Q36331619 | Clinical and critical care concerns in severely ill obese patient |
| Q92740278 | Comparative Evaluation of Dexmedetomidine versus Midazolam as Premedication to Propofol Anesthesia in Endoscopic Retrograde Cholangiopancreatography |
| Q48157709 | Comparison of effects of dexmedetomidine-ketamine and dexmedetomidine-midazolam combinations in transurethral procedures |
| Q35393084 | Dexmedetomidine versus midazolam for gastrointestinal endoscopy: a meta-analysis |
| Q48654372 | Dexmedetomidine: a guide to its use for sedation in the US. |
| Q37910905 | Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation |
| Q38033156 | Fospropofol disodium (lusedra) injection for anesthesia-care sedation: a clinical review. |
| Q43203223 | Fospropofol disodium injection for the sedation of patients undergoing colonoscopy |
| Q37614092 | Fospropofol: a new sedative-hypnotic agent for monitored anesthesia care |
| Q35135376 | Fospropofol: clinical pharmacology |
| Q45279289 | Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism |
| Q46739458 | Improved sedation with dexmedetomidine-remifentanil compared with midazolam-remifentanil during catheter ablation of atrial fibrillation: a randomized, controlled trial. |
| Q55476359 | Metabolic Profiles of Propofol and Fospropofol: Clinical and Forensic Interpretative Aspects. |
| Q33903587 | Novel anesthetic technique for combined intracavitary and interstitial brachytherapy for cervix cancer in an outpatient setting |
| Q24201692 | Pain management for tubal sterilization by hysteroscopy |
| Q24235759 | Pain management for tubal sterilization by hysteroscopy |
| Q42160283 | Perspectives on the role of fospropofol in the monitored anesthesia care setting. |
| Q46099520 | Predictors of hemodynamic compromise with propofol during defibrillator implantation: a single center experience |
| Q37777301 | Review of Propofol and Auxiliary Medications Used for Sedation |
| Q33998081 | Safety of midazolam for sedation of HIV-positive patients undergoing colonoscopy |
| Q38087409 | Safety of procedural sedation in pregnancy. |
| Q37710872 | Sedation in oral and maxillofacial day care surgery: A comparative study between intravenous dexmedetomidine and midazolam |
| Q39173826 | Subanesthetic, Subcutaneous Ketamine Infusion Therapy in the Treatment of Chronic Nonmalignant Pain |
| Q47792229 | The effect of midazolam on the recovery quality, recovery time and the minimum alveolar concentration for extubation in the isoflurane-anesthetized pig. |
| Q38710897 | Valeriana officinalis L. for conscious sedation of patients submitted to impacted lower third molar surgery: A randomized, double-blind, placebo-controlled split-mouth study |
| Q90704095 | [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics] |
Search more.